Delivery Order SPE2DB22D2211-SPE2DB25FSCMT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a $2.27K delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on September 4, 2025, with completion targeted for September 5, 2025. This firm fixed-price, non-set-aside contract represents a direct award under competitive procurement procedures and will be performed at the contractor's Conshohocken, Pennsylvania facility. Kerendia is a prescription medication used in the treatment of chronic kidney disease, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,789.31 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. Kerendia is a branded pharmaceutical product used in the treatment of chronic kidney disease, representing a...
- The Defense Logistics Agency awarded a $3,830.45 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This non-set-aside competitive award is scheduled for completion by August 14, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, reflecting the federal government's ongoing...
- The Defense Logistics Agency awarded a $5,008.41 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Kerendia 10 mg, a medication used in the treatment of chronic kidney disease. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $9,815.55 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitive award, issued without set-aside designation, carries a firm fixed price structure and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,571.07 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $5,211.66 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kerendia 10 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) valued at $3,603.95. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 20 mg, a pharmaceutical product for the treatment of chronic kidney disease. This delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed price contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCMTDelivery Order
The Defense Logistics Agency awarded a $1,511.98 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Kerendia 10 mg tablets (30-count package). This firm fixed-price, non-set-aside contract is scheduled for completion by August 11, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a medication used in the treatment of chronic kidney disease and related conditions, representing a critical pharmaceutical commodity for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.99 million through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen supplies an extensive portfolio of medications and medical commodities to support military healthcare operations globally, including specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic categories. The company's role as a strategic pharmaceutical distributor demonstrates its established capability to meet federal procurement requirements through competitive award processes and serves defense health agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/8/25 |